Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-97-002373
Filing Date
1997-03-28
Accepted
1997-03-28 00:00:00
Documents
11
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR YEAR ENDED DECEMBER 31, 1996 10-K 337943
2 AMENDMENT NO.2 TO LICENSE AGREEMENT EX-10.2 25685
3 AMENDMENT TO RESEARCH AGREEMENT EX-10.15 8264
4 COMMERCIAL FACTORING AGREEMENT EX-10.55 40794
5 LICENSE AND DISTRO AGREEMENT EX-10.56 26661
6 CREDIT AGREEMENT EX-10.57 72810
7 SECURITIES PURCHASE AGREEMENT EX-10.58 109560
8 EARNINGS PER SHARE EX-11.1 1322
9 SUBSIDIARIES EX-21.1 834
10 CONSENT OF INDEPENDENT AUDITORS EX-23.1 1070
11 FINANCIAL DATA SCHEDULE EX-27 2265
  Complete submission text file 0000950134-97-002373.txt   629697
Mailing Address 2860 WILDERNESS PL BOULDER CO 80301
Business Address 2860 WILDERNESS PLACE BOULDER CO 80301 3034445893
NEXSTAR PHARMACEUTICALS INC (Filer) CIK: 0000915359 (see all company filings)

EIN.: 841173453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23012 | Film No.: 97567430
SIC: 2834 Pharmaceutical Preparations